dsip review (Delta Sleep Inducing Peptide) DSIP Review: The Sleep Peptide

The filing is based on results from Novos Phase III REDEFINE 1 trial

Sofa Samper from the Hospital Miguel Servet provided clinical isolates from specific M

C14H22N4O9) is a synthetic tetrapeptide supplied for qualified laboratory research use

Early-phase clinical trials including a Phase 2 dose-ranging study published in the New England Journal of Medicine (2023) have demonstrated significant potential for weight reduction and metabolic improvement, generating considerable scientific interest

Patients in trials typically begin to notice appetite suppression and early weight loss within the first few weeks of treatment